TB4
People mainly take TB4 for skin & hair. Based on 3 first-hand reports. Ranked #1363 of 1,974 overall.
14
User score
Mostly positive33% positive0% mixed0% negative67% unclear
Of reports that state an outcome, 100% are positive.
Clinical research
Research pending
High-risk compound. Peptides are not approved as supplements, carry serious and sometimes irreversible risks, are banned in competitive sport and may be restricted where you live. Nothing here is a recommendation to use it.
What TB4 does, according to users
Of the people who reported each effect, the share who said it got better.
betterno changeworse
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
Research data for TB4 is being compiled.
Dosage people report
As stated by users — not a recommendation. Follow the label or your doctor.
750 mcgdaily
roughly a month protocolas reported
Reported side effects
How often each side effect came up across all reports.
No side effects reported so far.
What users say
Verbatim quotes, shortened only — each links to the original discussion.
“TB4, Frag ordered 2/24, Delivered 2/26”
“100 mcg ghk, 750 tb4 mcg sub Q daily”
“Roughly a month protocol of TB4 (its full frag), BPC-157, Tesa/Ipa for a research subject.”
Other options for skin & hair
Magnesium Glycinate
Supplement · 910 reports
67% report better skin & hair
Mostly positiveCResearch: Limited
Cardio
Lifestyle · 52 reports
67% report better skin & hair
Mostly positive
Exercise
Lifestyle · 405 reports
100% report better skin & hair
Mostly positive
Klow
Peptide · 32 reports
100% report better skin & hair
Mostly positiveDResearch: None
Black Seed Oil
Supplement · 111 reports
67% report better skin & hair
Mostly positiveBResearch: Moderate
Creatine
Supplement · 782 reports
12% report better skin & hair
Mostly positiveAResearch: Strong
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 2, 2026. How we rate